Epidemiology of breast cancer

Last updated
Age-standardized deaths from breast cancer per 100,000 inhabitants in 2004. .mw-parser-output .legend{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .legend-color{display:inline-block;min-width:1.25em;height:1.25em;line-height:1.25;margin:1px 0;text-align:center;border:1px solid black;background-color:transparent;color:black}.mw-parser-output .legend-text{} no data <2 2-4 4-6 6-8 8-10 10-12 12-14 14-16 16-18 18-20 20-22 >22 Breast cancer world map - Death - WHO2004.svg
Age-standardized deaths from breast cancer per 100,000 inhabitants in 2004.

Worldwide, breast cancer is the most common invasive cancer in women. [note 1] Breast cancer comprises 22.9% of invasive cancers in women [2] and 16% of all female cancers. [3]

Contents

In 2008, breast cancer caused 458,503 deaths worldwide, which is 13.7% of cancer deaths in women and 6.0% of all cancer deaths for men and women together. [2] Lung cancer, the second most common cause of cancer-related death in women, caused 12.8% of cancer deaths in women, which is 18.2% of all cancer deaths for men and women together. [2]

The number of cases worldwide has significantly increased since the 1970s, a phenomenon partly attributed to the modern lifestyles. [4] [5]

By age group

Breast cancer is strongly related to age, with only 5% of all breast cancers occurring in women under 40 years old. [6]

By region

The incidence of breast cancer varies greatly around the world: it is lowest in less-developed countries and greatest in the more-developed countries. [7] In the twelve world regions, the annual age-standardized incidence rates per 100,000 women are as follows: in Eastern Asia, 18; South Central Asia, 22; sub-Saharan Africa, 22; South-Eastern Asia, 26; North Africa and Western Asia, 28; South and Central America, 42; Eastern Europe, 49; Southern Europe, 56; Northern Europe, 73; Oceania, 74; Western Europe, 78; and in North America, 90. [8]

United States

Cancer occurrence in females in the US Most common cancers - female, by occurence.png
Cancer occurrence in females in the US
Cancer occurrence in women in the US by mortality. Most common cancers - female, by mortality.png
Cancer occurrence in women in the US by mortality.

The lifetime risk for breast cancer in the United States is usually given as about 1 in 8 (12%) of women by age 95, with a 1 in 35 (3%) chance of dying from breast cancer. [10] This calculation assumes that all women live to at least age 95, except for those who die from breast cancer before age 95. [11] Recent work, using real-world numbers, indicate that the actual risk is probably less than half the theoretical risk. [12]

The United States has the highest annual incidence rates of breast cancer in the world; 128.6 per 100,000 in whites and 112.6 per 100,000 among African Americans. [10] [13] It is the second-most common cancer (after skin cancer) and the second-most common cause of cancer death (after lung cancer) in women. [10] In 2007, breast cancer was expected to cause 40,910 deaths in the US (7% of cancer deaths; almost 2% of all deaths). [14] This figure includes 450-500 annual deaths among men out of 2000 cancer cases. [15]

In the US, both incidence and death rates for breast cancer have been declining in the last few years. [14] [16] In the US, the age-adjusted incidence of breast cancer per 100,000 women rose from around 102 cases per year in the 1970s to around 141 in the late 1990s, and has since fallen, holding steady around 125 since 2003. Age-adjusted deaths from breast cancer per 100,000 women rose slightly from 31.4 in 1975 to 33.2 in 1989 and have declined steadily since, to 20.5 in 2014. [17] Nevertheless, a US study conducted in 2005 indicated that breast cancer remains the most feared disease, [18] even though heart disease is a much more common cause of death among women. [19] Studies suggest that women overestimate their risk of breast cancer. [20]

UK

Breast cancer incidence by age in women (UK) 2006-08 Breast cancer incidence by age in women in the UK 2006-2008.png
Breast cancer incidence by age in women (UK) 2006-08

Breast cancer is the most common cancer in the UK (around 49,900 women and 350 men were diagnosed with the disease in 2011), and it is the third most common cause of cancer death (around 11,600 women and 75 men died in 2012). [22] The age-standardised incidence rate of breast cancer is 113.4 per 100,000 populations in Wales and there has been a significant increase in the incidence of breast cancer in Wales over the last three decades, which is likely to be partly due to the introduction of the National Health Service Breast Screening Programme. [23]

Developing countries

"Breast cancer in less developed countries, such as those in South America, is a major public health issue. It is a leading cause of cancer-related deaths in women in countries such as Argentina, Uruguay, and Brazil. The expected numbers of new cases and deaths due to breast cancer in South America for the year 2001 are approximately 70,000 and 30,000, respectively." [24] However, because of a lack of funding and resources, treatment is not always available to those suffering with breast cancer. It has also been shown that while the overall incidence of breast cancer appears to be higher in Caucasian women, black African women tend to present at a younger age and with a more aggressive disease pattern, a pattern that has also been reported among black women born and bred in London suggesting a more genetic link rather than only an environmental cause or late presentation. [25]

Sub-Saharan Africa

Incidence and Mortality

Data on breast cancer in Sub Saharan Africa is available, though extremely limited compared to developed countries. [26] Breast cancer has the highest incidence among Sub Saharan African women, and has now also the highest mortality rate in many of the countries in the region, before cervical cancer. [27] Breast cancer causes 20% of cancer deaths in women and represents 25% of cancers diagnosed. [27] Incidence rates of breast cancer varies from region to region in Sub Saharan Africa and are 30.4, 26.8, 38.6 and 38.9 respectively in Eastern Africa, Central Africa, Western Africa and Southern Africa. [28] Sub Saharan Africa has lower incidence rates for breast cancer than developed countries but the mortality rates reflected in the region are much higher. [27] [29] Many reasons were found to be the source of this disparity, including the fact that breast cancer is diagnosed at later stages in Sub Saharan Africa. [29] For example, while Central Africa had a mortality/incidence ratio of 0.55 in 2012, the US had only 0.16. [26] In addition to being diagnosed at later stages, breast cancer in Sub Saharan Africa was also found to have an earlier onset compared to western countries. [27] Screening is considered an important tool to tackle the late stage diagnosis of breast cancer by most policy makers in African Countries, especially given that treatment is greatly limited by the lack of resources. [26] [30] More research is also required to produce more updated data on breast cancer and better understand the variances there and how they affect the burden of the disease in the region. [26] [29] [30]

Challenges

One of the major challenges in reducing the burden of breast cancer in Sub Saharan Africa remains the lack of National Cancer Control Programs and the lack of human as well as financial resources. [26] The majority of countries lack integrated prevention and treatment programs, which complicates the control of the disease in those countries. Also, the regions disposes of a disproportionally low number of cancer registries, along with resources and facilities for treatment. [27] This all factors into the different countries' difficulties to ensure that women at high risk are identified and that the disease is diagnosed early enough to have better chances of being treated. [26] [27] The lack of affordable and effective treatment methods also renders the efforts to promote early detection because those affected are then faced with inaccessible and unaffordable resources in the cases where they are available. [26] The challenges to tackling breast cancer in Africa are varied, not fully understood, and further complicated by possible unique risk factors that could be highlighted by further studies, [27] but developing strategies that foster early detection are viewed in literature as a priority for effective fight against the disease. [31]

Male breast cancer

Male breast cancer is a much less talked about issue due to its lower incidence with less than 1% of breast cancer in Sub Saharan Africa. [32] A review of the disease found that male to female ratio was higher in Sub Saharan Countries than in developed countries and that onset of the disease occurred on average 7 years later in men than in women. [32] There is a noticeable decrease in the male to female breast cancer ratio in recent years but that might be associated to the recent increase in female breast cancer in the region. There is still little understanding of the causes of the higher risk for male breast cancer in Sub Saharan Africa and on male breast cancer in general, leading to poor clinical management of the disease. [32]

See also

Notes

  1. ↑ The most common form of cancer is non-invasive non-melanoma skin cancer; non-invasive cancers are generally easily cured, cause very few deaths, and are routinely excluded from cancer statistics.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Cervical cancer</span> Cancer arising from the cervix

Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Early on, typically no symptoms are seen. Later symptoms may include abnormal vaginal bleeding, pelvic pain or pain during sexual intercourse. While bleeding after sex may not be serious, it may also indicate the presence of cervical cancer.

<span class="mw-page-title-main">Breast cancer</span> Cancer that originates in mammary glands

Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, milk rejection, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.

<span class="mw-page-title-main">Non-Hodgkin lymphoma</span> Type of cancer of lymph nodes

Non-Hodgkin lymphoma (NHL), also known as non-Hodgkin's lymphoma, is a group of blood cancers that includes all types of lymphomas except Hodgkin lymphomas. Symptoms include enlarged lymph nodes, fever, night sweats, weight loss, and tiredness. Other symptoms may include bone pain, chest pain, or itchiness. Some forms are slow-growing while others are fast-growing.

<span class="mw-page-title-main">Prostate cancer</span> Male reproductive organ cancer

Cancer of the prostate is the second most common cancerous tumor worldwide and is the fifth leading cause of cancer-related mortality among men. The prostate is a gland in the male reproductive system that surrounds the urethra just below the bladder. Most prostate cancers are slow growing. Cancerous cells may spread to other areas of the body, particularly the bones and lymph nodes. It may initially cause no symptoms. In later stages, symptoms include pain or difficulty urinating, blood in the urine, or pain in the pelvis or back. Benign prostatic hyperplasia may produce similar symptoms. Other late symptoms include fatigue, due to low levels of red blood cells.

<span class="mw-page-title-main">Cancer</span> Group of diseases involving abnormal cell growth and spread

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. While these symptoms may indicate cancer, they can also have other causes. Over 100 types of cancers affect humans.

<span class="mw-page-title-main">Colorectal cancer</span> Cancer of the colon or rectum

Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and fatigue. Most colorectal cancers are due to old age and lifestyle factors, with only a small number of cases due to underlying genetic disorders. Risk factors include diet, obesity, smoking, and lack of physical activity. Dietary factors that increase the risk include red meat, processed meat, and alcohol. Another risk factor is inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis. Some of the inherited genetic disorders that can cause colorectal cancer include familial adenomatous polyposis and hereditary non-polyposis colon cancer; however, these represent less than 5% of cases. It typically starts as a benign tumor, often in the form of a polyp, which over time becomes cancerous.

<span class="mw-page-title-main">Esophageal cancer</span> Gastrointestinal system cancer that is located in the esophagus

Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach. Symptoms often include difficulty in swallowing and weight loss. Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a dry cough, and possibly coughing up or vomiting blood.

<span class="mw-page-title-main">Mammography</span> Process of using low-energy X-rays to examine the human breast for diagnosis and screening

Mammography is the process of using low-energy X-rays to examine the human breast for diagnosis and screening. The goal of mammography is the early detection of breast cancer, typically through detection of characteristic masses or microcalcifications.

<span class="mw-page-title-main">Uterine cancer</span> Medical condition

Uterine cancer, also known as womb cancer, includes two types of cancer that develop from the tissues of the uterus. Endometrial cancer forms from the lining of the uterus, and uterine sarcoma forms from the muscles or support tissue of the uterus. Endometrial cancer accounts for approximately 90% of all uterine cancers in the United States. Symptoms of endometrial cancer include changes in vaginal bleeding or pain in the pelvis. Symptoms of uterine sarcoma include unusual vaginal bleeding or a mass in the vagina.

<span class="mw-page-title-main">Kidney cancer</span> Medical condition

Kidney cancer, also known as renal cancer, is a group of cancers that starts in the kidney. Symptoms may include blood in the urine, lump in the abdomen, or back pain. Fever, weight loss, and tiredness may also occur. Complications can include spread to the lungs or brain.

<span class="mw-page-title-main">Oral cancer</span> Cancer of the lining of the lips, mouth, or upper throat

Oral cancer, also known as mouth cancer, is cancer of the lining of the lips, mouth, or upper throat. In the mouth, it most commonly starts as a painless white patch, that thickens, develops red patches, an ulcer, and continues to grow. When on the lips, it commonly looks like a persistent crusting ulcer that does not heal, and slowly grows. Other symptoms may include difficult or painful swallowing, new lumps or bumps in the neck, a swelling in the mouth, or a feeling of numbness in the mouth or lips.

Women's health differs from that of men in many unique ways. Women's health is an example of population health, where health is defined by the World Health Organization as "a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity". Often treated as simply women's reproductive health, many groups argue for a broader definition pertaining to the overall health of women, better expressed as "The health of women". These differences are further exacerbated in developing countries where women, whose health includes both their risks and experiences, are further disadvantaged.

<span class="mw-page-title-main">Invasive carcinoma of no special type</span> Medical condition

Invasive carcinoma of no special type (NST) is also referred to as invasive ductal carcinoma or infiltrating ductal carcinoma(IDC) and invasive ductal carcinoma, not otherwise specified (NOS). Each of these terms represents to the same disease entity, but for international audiences this article will use invasive carcinoma NST because it is the preferred term of the World Health Organization (WHO).

<span class="mw-page-title-main">Epidemiology of HIV/AIDS</span> Epidemic of human immunodeficiency virus

The global epidemic of HIV/AIDS began in 1981, and is an ongoing worldwide public health issue. According to the World Health Organization (WHO), as of 2021, HIV/AIDS has killed approximately 40.1 million people, and approximately 38.4 million people are infected with HIV globally. Of these 38.4 million people, 75% are receiving antiretroviral treatment. There were about 770,000 deaths from HIV/AIDS in 2018, and 650,000 deaths in 2021. The 2015 Global Burden of Disease Study estimated that the global incidence of HIV infection peaked in 1997 at 3.3 million per year. Global incidence fell rapidly from 1997 to 2005, to about 2.6 million per year. Incidence of HIV has continued to fall, decreasing by 23% from 2010 to 2020, with progress dominated by decreases in Eastern Africa and Southern Africa. As of 2020, there are approximately 1.5 million new infections of HIV per year globally.

<span class="mw-page-title-main">Screening (medicine)</span> Brief medical evaluation to detect unnoticed health problems

Screening, in medicine, is a strategy used to look for as-yet-unrecognised conditions or risk markers. This testing can be applied to individuals or to a whole population. The people tested may not exhibit any signs or symptoms of a disease, or they might exhibit only one or two symptoms, which by themselves do not indicate a definitive diagnosis.

<span class="mw-page-title-main">Liver cancer</span> Medical condition

Liver cancer is cancer that starts in the liver. Liver cancer can be primary or secondary. Liver metastasis is more common than that which starts in the liver. Liver cancer is increasing globally.

<span class="mw-page-title-main">Epidemiology of cancer</span> The study of factors in cancer causes and treatments

The epidemiology of cancer is the study of the factors affecting cancer, as a way to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments.

<span class="mw-page-title-main">Epidemiology of pneumonia</span>

Pneumonia is a common respiratory infection, affecting approximately 450 million people a year and occurring in all parts of the world. It is a major cause of death among all age groups, resulting in 1.4 million deaths in 2010 and 3.0 million deaths in 2016.

<span class="mw-page-title-main">Childhood cancer</span> Medical condition

Childhood cancer is cancer in a child. About 80% of childhood cancer cases can be successfully treated. thanks to the modern medical treatments and optimal patient care. However, only about 10% of children diagnosed with cancer reside in high-income countries where the necessary treatments and care is available. Childhood cancer represents only about 1% of all types of cancers diagnosed in children and adults. For this reason, childhood cancer is often ignored in control planning, contributing to the burden of missed opportunities for its diagnoses and management in countries that are low- and mid-income.

<span class="mw-page-title-main">Gynecologic cancer disparities in the United States</span>

Gynecologic cancer disparities in the United States refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer. For patients with these and other gynecologic malignancies within the United States, disparities across the care continuum by socioeconomic status and racial/ethnic background have been previously identified and studied. The causes behind these disparities are multifaceted and a complex interplay of systemic differences in health as well as individual patient factors such as cultural, educational, and economic barriers.

References

  1. ↑ "WHO Disease and injury country estimates". World Health Organization. 2009. Retrieved Nov 11, 2009.
  2. 1 2 3 "World Cancer Report". International Agency for Research on Cancer. 2008. Archived from the original on 2011-01-14. Retrieved 2011-02-26.(cancer statistics often exclude non-melanoma skin cancers such as basal cell carcinoma which though very common are rarely fatal)
  3. ↑ "Breast cancer: prevention and control". World Health Organization. Archived from the original on 2015-09-06.
  4. ↑ Laurance, Jeremy (2006-09-29). "Breast cancer cases rise 80% since Seventies". The Independent . London. Archived from the original on April 25, 2008. Retrieved 2006-10-09.
  5. ↑ "Breast Cancer: Statistics on Incidence, Survival, and Screening". [Imaginis Corporation]. 2006. Retrieved 2006-10-09.
  6. ↑ Breast Cancer: Breast Cancer in Young Women WebMD. Retrieved on September 9, 2009
  7. ↑ Youlden, Danny R. (Winter 2012). "The Descriptive Epidemiology of Female Breast Cancer: An International Comparison of Screening, Incidence, Survival and Mortality" (PDF). Cancer Epidemiology. 36 (3): 237–248. doi:10.1016/j.canep.2012.02.007. hdl: 10072/67027 . PMID   22459198.
  8. ↑ B. W. and Kleihues P. (Eds): World Cancer Report. IARCPress. Lyon 2003 [ permanent dead link ]
  9. 1 2 Jemal A, Siegel R, Ward E, et al. (2008). "Cancer statistics, 2008". CA Cancer J Clin. 58 (2): 71–96. doi: 10.3322/CA.2007.0010 . PMID   18287387.
  10. 1 2 3 American Cancer Society (September 13, 2007). "What Are the Key Statistics for Breast Cancer?". Archived from the original on January 5, 2008. Retrieved 2008-02-03.
  11. ↑ Olson, 2002. pages 199–200.
  12. ↑ W.B. Cutler; R.E. Burki; E. Genovesse; M.G. Zacher (September 2009). "Breast cancer in postmenopausal women: what is the real risk?". Fertility and Sterility. 92 (3): S16. doi: 10.1016/j.fertnstert.2009.07.061 .
  13. ↑ "Browse the SEER Cancer Statistics Review 1975–2006".
  14. 1 2 American Cancer Society (2007). "Cancer Facts & Figures 2007" (PDF). Archived from the original (PDF) on April 10, 2007. Retrieved 2007-04-26.
  15. ↑ "Male Breast Cancer Causes, Risk Factors for Men, Symptoms and Treatment on". Medicinenet.com. Retrieved 2010-05-08.
  16. ↑ Espey DK, Wu XC, Swan J, et al. (2007). "Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives". Cancer. 110 (10): 2119–52. doi: 10.1002/cncr.23044 . PMID   17939129. S2CID   25675721.
  17. ↑ "Female Breast Cancer - Cancer Stat Facts".
  18. ↑ "Women's Fear of Heart Disease Has Almost Doubled in Three Years, But Breast Cancer Remains Most Feared Disease" (Press release). Society for Women's Health Research. 2005-07-07. Archived from the original on 2007-10-21. Retrieved 2007-10-15.
  19. ↑ "Leading Causes of Death for American Women 2004" (PDF). National Heart Lung and Blood Institute. Archived from the original (PDF) on 2007-10-25. Retrieved 2007-10-15.
  20. ↑ In Breast Cancer Data, Hope, Fear and Confusion, By DENISE GRADY, New York Times, January 26, 1999.
  21. ↑ chart for Figure 1.1: Breast Cancer (C50), Average Number of New Cases per Year and Age-Specific Incidence Rates, UK, 2006-2008 at Breast cancer - UK incidence statistics Archived 2012-05-14 at the Wayback Machine at Cancer Research UK. Section updated 18/07/11.
  22. ↑ "Breast cancer statistics". Cancer Research UK. 2015-05-14. Retrieved 27 October 2014.
  23. ↑ Abdulrahman, Ganiy Opeyemi (2 May 2017). "Breast cancer in Wales: time trends and geographical distribution". Gland Surgery. 3 (4): 237–242. doi:10.3978/j.issn.2227-684X.2014.11.01. PMC   4244508 . PMID   25493255.
  24. ↑ (Schwartzmann, 2001, p 118)
  25. ↑ Abdulrahman, Ganiy Opeyemi; Rahman, Ganiyu Adebisi (1 January 2012). "Epidemiology of breast cancer in europe and Africa". Journal of Cancer Epidemiology. 2012: 915610. doi: 10.1155/2012/915610 . PMC   3368191 . PMID   22693503.
  26. 1 2 3 4 5 6 7 Pace, Lydia E.; Shulman, Lawrence N. (2016-06-01). "Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality". The Oncologist. 21 (6): 739–744. doi:10.1634/theoncologist.2015-0429. ISSN   1083-7159. PMC   4912363 . PMID   27091419.
  27. 1 2 3 4 5 6 7 Brinton, Louise A.; Figueroa, Jonine D.; Awuah, Baffour; Yarney, Joel; Wiafe, Seth; Wood, Shannon; Ansong, Daniel; Nyarko, Kofi; Wiafe-Addai, Beatrice (April 2014). "Breast Cancer in Sub-Saharan Africa: Opportunities for Prevention". Breast Cancer Research and Treatment. 144 (3): 467–478. doi:10.1007/s10549-014-2868-z. ISSN   0167-6806. PMC   4023680 . PMID   24604092.
  28. ↑ Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] Lyon, France: International Agency for Research on Cancer; 2013.
  29. 1 2 3 Espina, Carolina (2017-09-17). "Delayed presentation and diagnosis of breast cancer in African women: a systematic review". Annals of Epidemiology. 27 (10): 659–671.e7. doi:10.1016/j.annepidem.2017.09.007. PMC   5697496 . PMID   29128086.
  30. 1 2 Youlden, Danny R.; Cramb, Susanna M.; Dunn, Nathan A. M.; Muller, Jennifer M.; Pyke, Christopher M.; Baade, Peter D. (2012-06-01). "The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality" (PDF). Cancer Epidemiology. 36 (3): 237–248. doi:10.1016/j.canep.2012.02.007. hdl: 10072/67027 . PMID   22459198.
  31. ↑ Jedy-Agba, Elima; McCormack, Valerie; Adebamowo, Clement; dos-Santos-Silva, Isabel (2016-12-01). "Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis". The Lancet Global Health. 4 (12): e923–e935. doi:10.1016/S2214-109X(16)30259-5. ISSN   2214-109X. PMC   5708541 . PMID   27855871.
  32. 1 2 3 Ndom, Paul (June 2017). "A meta-analysis of male breast cancer in Africa". The Breast. 21 (3): 237–241. doi: 10.1016/j.breast.2012.01.004 . PMID   22300703.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.